CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Drugs (New Approvals & NDA)
Original article

July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee - 07/23/2026

Neutral
AI Analysis

Summary

The FDA Pharmacy Compounding Advisory Committee will meet on July 23-24, 2026 to discuss bulk drug substances for potential inclusion on the 503A Bulks List.

Importance:1/10
Sentiment:
0.00
FDAAdvisory CommitteePharmacy Compounding503A Bulks List

Read the original article

Published by FDA Drugs (New Approvals & NDA) on August 6, 2026 7:44 PM

Read Original